Stifel Nicolaus Forecasts Strong Price Appreciation for Envista (NYSE:NVST) Stock

Envista (NYSE:NVST) had its price target upped by stock analysts at Stifel Nicolaus from $25.00 to $27.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Stifel Nicolaus’ price objective would suggest a potential upside of 17.85% from the company’s current price.

Other research analysts have also recently issued reports about the company. Piper Sandler upped their price objective on Envista from $19.00 to $21.00 and gave the company a “neutral” rating in a report on Friday. JPMorgan Chase & Co. lifted their target price on Envista from $20.00 to $22.00 and gave the company a “neutral” rating in a research report on Tuesday, December 16th. Barclays began coverage on Envista in a research note on Monday, December 8th. They issued an “overweight” rating and a $24.00 price target on the stock. Evercore ISI reissued an “outperform” rating on shares of Envista in a research report on Friday, October 31st. Finally, UBS Group upped their target price on shares of Envista from $22.00 to $25.00 and gave the company a “neutral” rating in a research report on Tuesday. Five equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Envista has an average rating of “Hold” and an average target price of $22.75.

Envista Price Performance

Shares of NVST stock opened at $22.91 on Wednesday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.37 and a quick ratio of 2.02. The company has a market capitalization of $3.77 billion, a PE ratio of 254.58, a price-to-earnings-growth ratio of 1.04 and a beta of 1.01. The firm’s 50-day moving average is $22.50 and its two-hundred day moving average is $21.12. Envista has a 12 month low of $14.22 and a 12 month high of $25.41.

Hedge Funds Weigh In On Envista

Institutional investors have recently bought and sold shares of the company. Farther Finance Advisors LLC lifted its position in shares of Envista by 317.6% during the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock worth $27,000 after purchasing an additional 1,026 shares in the last quarter. Caitong International Asset Management Co. Ltd increased its stake in Envista by 16,711.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after buying an additional 1,504 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Envista by 73.1% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after buying an additional 949 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in Envista by 378.0% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock worth $47,000 after buying an additional 1,909 shares in the last quarter. Finally, SJS Investment Consulting Inc. boosted its position in Envista by 10,356.5% in the 3rd quarter. SJS Investment Consulting Inc. now owns 2,405 shares of the company’s stock valued at $49,000 after buying an additional 2,382 shares during the period.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.